Introduction
Human herpesvirus 6 (HHV-6) was first detected by Salahuddin et al. (1986) and has been isolated from patients with immunoproliferative disorders and retrovirus infections (Downing et al., 1987; Tedder et al., 1987; Agut et al., 1988; Lopez et al., 1988) . HHV-6 nucleotide sequences have been detected also in tissue samples from patients with lymphoid malignancies (Jarrett et al., 1988; Josephs et al., 1988) . Serological investigations have shown that the majority of the adult population is seropositive for HHV-6 and that the virus is acquired in infancy (Briggs et al., 1988; Saxinger et al., 1988; Clark et al., 1990) . HHV-6 is the causative agent of exanthem subitum, a common childhood infection (Yamanashi et al., 1988) . The virus is able to infect populations of lymphoid cells in vivo, and virus and DNA sequences have been detected in saliva (Pietroboni et al., 1988) . In vitro, the virus can be propagated in a number of lymphoblastoid cell lines (Tedder et al., 1987; Lusso et al., 1988) . Sequence analysis of a 21 kb fragment shows that HHV-6 is more closely related to human cytomegalovirus than to the gammaherpesviruses Epstein-Barr virus (EBV) and herpesvirus saimiri .
To date, studies relating to gene activation by HHV-6 have concentrated on its interaction with human immunodeficiency virus (HIV), because HHV-6 is considered to be a possible cofactor in the development of acquired immunodeficiency syndrome. Ensoli et al. (1989) and Lusso et al. (1989) have found that HHV-6 can productively co-infect CD4 ÷ T cells causing an accelerated c.p.e, and increased HIV expression. However, studies by Pietroboni et al. (1988) and Lopez et al. (1988) found that HHV-6 inhibits HIV replication, as shown by decreased reverse transcriptase activity and virus titre. Infection of cells transfected with HIV long terminal repeat sequence (LTR)-chloramphenicol acetyltransferase (CAT) constructs caused increased CAT activity, suggesting that HHV-6-responsive elements are located within the LTR (Horvat et al., 1989; Lusso et al., 1989) . Further studies showed parallel increases of mRNA and mapped potential HHV-6-responsive elements to a region of the HIV LTR containing the NFkB binding sites.
Our aim was to study the effect of HHV-6 infection on transcription directed by the human T cell leukaemia virus type I (HTLV-I) LTR, as there is the potential for the two viruses to interact in rico because both have similar cell tropisms and HHV-6 has been isolated from patients with retroviral infections. In addition, we hoped to gain a greater understanding of the replicative cycle of HHV-6. The results obtained show that although expression of HTLV-I LTR-CAT constructs is up-regulated by HHV-6 infection, this effect is not due to specific HTLV-I sequences and is likely to be mediated by a post-transcriptional mechanism. These conclusions are supported by additional studies using constructs containing the HIV LTR and a family of plasmids containing defined lesions in the herpes simplex virus type 1 (HSV-1) glycoprotein D (gD) gene promoter. In no case were specific promoter sequences found to be essential for the activation of gene expression during infection with HHV-6.
Methods
Cell lines and virus stocks. A Jurkat cell line (J. Jhan) was used for transfection assays and virus growth. C8166 (Salahuddin et al., 1983) cell lines were used for S1 analysis. Both T lymphocyte cell lines were maintained in RPMI 1640 containing 10~ foetal bovine serum, 400 international units/m/penicillin and 400 v.g/ml streptomycin. Infections were carried out using the A72 isolate of HHV-6 (Tedder et al., 1987) . HHV-6-infected cells were identified using an indirect immunofluorescence assay (Clark et al., 1990) .
DNA transfections. DNA was transfected into ceils using the DEAEdextran method. The DNA (4 ~tg of recorder construct plus 6 ~tg pUC8 or trans-activator gene) was mixed with 1 m125 mM-Tris-HCl pH 7.4, 137 m/a-NaCl, 5 mra-KC1, 0-6 mM-Na2HPO4, 0.7 mM-CaC12, 0.5 mMMgCI2 and 400 ~tg/ml DEAE-dextran and added to 2x 107 cells. The cells were incubated at 37 °C for 90 min and then 15~ DMSO was added for 3 min. Following washing, 10 ml of medium or 5 ml of medium plus 5 ml of supernatant from infected cells was added and the cells were incubated for 48 h at 37 °C. The TCIDs0 of the infected cell medium was approximately 1 : 12 unless otherwise stated.
Reporter gene assays. CAT assays were carried out by incubating cytoplasmic cell extracts with 14C-labelled chloramphenicol and acetyl coenzyme A as described previously (Gorman et al., 1982) . Media and cytoplasmic extracts were assayed for growth hormone using the Allegro immunoassay system (Biogenesis). Thymidine kinase (TK) assays were carried out as described (Cordingley et al., 1983) . All results were calculated from readings within the linear range of the assay.
$1 nuclease mapping. Cytoplasmic RNA (20 ~tg) was precipitated with 5 x 104 Cerenkov counts of 5'-radiolabelled probe complementary to nucleotides 333 to 409 of the HTLV-I genome. The pellet was resuspended in 30 p.l 1 M-NaCI, 0.17 M-HEPES pH 7.5 and 0.33 M-EDTA, heated to 75 °C for 10 rain and then incubated overnight at 55 °C. S1 nuclease (300 units) in a final concentration of 0.28 M-NaC1, 50 mM sodium acetate pH 4-5, 4.5 mM-ZnSO4 was added and the mixture was incubated at 37 °C for 1 h. The reaction was stopped by adding 10 ktg tRNA and EDTA to 5 mM, and then RNA was ethanolprecipitated. The samples were dissolved in formamide dye, boiled and electrophoresed on an 8~ denaturing polyacrylamide gel.
Plasmid constructions. HIV and HTLV-I LTR-CAT constructs have been described previously (Arya et al., 1985; Felber et al., 1985) . p H2 CAT was constructed by inserting the 1.8 kb NdeI-BamHI LTR fragment from HTLV-1 LTR-CAT into the vector plC19H (Marsh et al., 1984) . pTax is a cDNA clone of the HTLV-I pX gene, derived from the C91PL cell line, in a vector flanked by the Moloney murine leukaemia virus LTRs (Cross et al., 1984) . pgD CAT and deletion mutants were derived from the pERD series (Everett, 1986) by removing the gD promoter region as an SstI-HindlII fragment and inserting it into a suitable site in a vector derived from pBLW2 (Everett, 1984) . Other plasmid constructs which have been described previously are pTKCAT (Lucklow & Schutz, 1987) , pTKGH (Selden et al., 1986) , pTK1 (Cordingley et aL, 1983) and pPRV IE (Campbell & Preston, 1987) . pgDGH was constructed by inserting the HindlII fragment of pgDCAT into the same site of p0GH (Selden et al., 1986) . NFTA-CAT was constructed by inserting a double-stranded oligonucleotide, residues -110 to -78 of the HIV LTR, between the SphI/XhoI sites of pSVgD. The SphI and XhoI sites of pSVgD were filled in and the plasmid was religated to form TA-CAT, which has the CAT gene under the control of the gD TATA box.
Results

Activation of HTLV-I LTR-CAT by HHV-6
In order to determine whether infection with HHV-6 could increase expression of an HTLV-I LTR-CAT construct, as had been previously found for HIV LTR constructs, transfection experiments were carried out. HIV and HTLV-I LTR-CAT constructs were introduced into J. Jhan cells (a T lymphocyte cell line) by using the DEAE-dextran transfection method. Following transfection, medium was added to the cells from uninfected or HHV-6-infected cultures. The cells were incubated for 2 days at 37 °C, harvested and the CAT activity was assayed. An exceptionally marked increase in CAT activity was observed from both the HTLV-I and HIV LTR-CAT constructs (Fig. 1) . In order to characterize this effect further, we studied the nature of the HHV-6 protein involved, the requirement for specific promoter sequences and the stage during the expression of the gene at which activation occurs.
To determine the time course of HHV-6 activation, cells were transfected with HTLV-I LTR-CAT, as described previously, and mock-infected or infected with HHV-6. The cells were harvested after various time intervals between 1 and 4 days and the CAT activity was measured. It was found that maximum activation occurred between 1 and 2 days after the addition of HHV-6 (Fig. 2) . The progression of infection, as monitored by the percentage of cells reacting with sera from infected patients, reached a maximum after 3 days of infection. These results indicate that one or more viral proteins which are present at early times of infection and subsequently decline in activity are responsible for the activation of gene expression.
Transcription mediated by the HTLV-I LTR is upregulated by tax, a 40K protein encoded by HTLV-I (Sodroski et al., 1984; Felber et al., 1985) . The HTLV-I LTR ( Fig. 3) contains three 21 bp repeat sequences which, when present in two or more copies, can act as a target for tax (Shimotohno et al., 1986; Brady et al., 1987) . tax does not interact directly with the repeat sequences but mediates LTR activation through cellular DNA-binding factors (Jeang et al., 1988; Montagne et al., 1990). To examine the effect of co-activation with tax and HHV-6, cells were transfected with HTLV-I LTR-CAT and either mock-infected, infected with HHV-6 or cotransfected with a plasmid carrying the HTLV-I tax gene. In this experiment, infection was carried out with diluted HHV-6 medium in order to obtain similar levels of induction by HTLV-I and tax. The results (Fig. 4) show that when both methods of activation are used together a very strong response is observed (69.5-fold induction), which is greater than the sum of the individual activations of 7.7-and 7-2-fold. As an additional control, HTLV-I LTR-CAT was cotransfected with the vector which contains the regulatory sequences of pTax but lacks the tax coding region. No stimulation was obtained with this plasmid in the absence or presence of HHV-6 medium (data not shown). The results obtained show that tax and HHV-6 act synergistically and imply that they have different mechanisms of activation.
To study the sequences required for HHV-6 activation we constructed a deletion mutant of HTLV-I LTR-CAT by removing sequences upstream of a position 55 bp from the initiation site. The resultant plasmid, pH2 CAT (Fig. 3) , contains the TATA box but lacks upstream regulatory elements such as the 21 bp repeat sequences. When pH2 CAT was introduced into cells its expression was increased 41.8-fold by HHV-6 infection, whereas in the same set of experiments HTLV-I LTR-CAT was stimulated 52.0-fold (Fig. 1) ira.
• ---77 bp g C A T expression were lower. This result showed that sequences upstream of residue -55 were not required for HHV-6 activation.
HHV-6 infection does not increase levels of HTL V-I mRNA
The C8166 cell line (Salahuddin et al., 1983) contains integrated defective HTLV-I proviruses, one of which is able to synthesize the doubly spliced form of m R N A which encodes tax; later species of R N A and infectious virus are not produced. To study the effect of HHV-6 on HTLV-I R N A levels, cytoplasmic R N A was isolated from cells which had been infected for 2 days with HHV-6 or from uninfected cells and was analysed by S1 nuclease mapping. A probe complementary to residues 333 to 409 of the H T L V -I genome (Seiki et al., 1983) which spanned the m R N A start site was hybridized to the R N A and electrophoresed on a denaturing gel following S1 digestion. Both samples of C8166 R N A (Fig. 5, lanes 2 and 3) differ from that of a transfected plasmid; however,
HHV-6 infection of cells transfected with H T L V -I L T R -
CAT, pgD CAT, or a plasmid expressing the rabbit flglobin gene under the control of the gD promoter, did not lead to detectable levels of m R N A transcripts from the transfected plasmids (data not shown). This contrasts with the situation during HSV-1 infection (Everett, 1984) .
Activation of gene expression during HHV-6 infection does not require specific promoter regulatory sequences
A number of herpesvirus trans-activators mediate transcriptional regulation via interaction with transcription factors which bind to basal promoter elements (Abmayer et al., 1985; McKnight & Tjian, 1986) . To investigate the promoter sequence required for activation by HHV-6, a series of fine deletion mutants of the HSV-I gD gene (Everett, 1983 (Everett, , 1984 were utilized (Fig.  6 ). The constructs were transfected into J. Jhan cells and infected with HHV-6 or mock-infected. Increases in CAT activity due to HHV-6 expression are shown in Table 1 . The level of activation of pgD CAT constructs was very high and, although some variation was observed (e.g. pgD CAT is activated 4400-fold and plasmid 25/4, which has a deletion in the T A T A box, is activated 1300-fold), this difference is small compared to the total level of induction. These results show that no essential promoter sequences are required for activation.
To determine further whether regulatory sequences containing NFkB binding sites play a role in HHV-6 activation, we constructed vectors which consisted of the CAT gene under the regulation of the T A T A box, with and without sequences between residues -110 and -78 of the HIV LTR, which contains two copies of the NFkB binding site. Both constructs (Fig. 7) responded strongly to HHV-6 and the effect of the NFkB site was found to be negligible.
HHV-6 activation is dependent on gene construct
We examined the effect of HHV-6 infection on the expression of different constructs under the regulation of the HSV-1 TK promoter to determine whether the nature of the reporter gene played any role in HHV-6 activation. The TK-CAT constructs, like all other CAT constructs tested, were strongly induced by HHV-6 infection (160-fold) (Table 2) . However, the construct in which the growth hormone (GH) gene was under the control of the TK promoter, pTKGH, was only induced 1-3-fold, showing that this construct had a very low, if any, response to infection. The TK gene regulated by its own t Average fold increase in activity due to HHV-6 infection or pPRV IE transfection.
:~ CAT activity expressed as acetylation (%)/p.g protein/h of assay. § Values are the average of three experiments.
II Range of values used to calculate average value. ¶ GH concentration, ng/ml. ** TK activity expressed as c.p.m./Ixg protein/h of assay. ttND, Not detectable above background levels of GH.
promoter gave an intermediate response (12.6-fold) to infection, pTKCAT, p T K G H and pTK1 were also cotransfected with pPRV IE, which encodes the pseudo- 4) . Ac. Cm., acetylated chloramphenicol; Cm., chloramphenicol.
rabies virus trans-activator, and levels of expression were increased 20.6-, 14.5-and 21-3-fold respectively. This control shows that there is no defect in p T K G H and that higher levels of G H can be expressed. An additional study showed that no significant increase in G H expression occurred following infection when the cells or media were harvested at times between 1 and 4 days (results not shown).
Using the gD deletion constructs, we showed that no specific promoter elements were essential for activation by HHV-6 (Table 1) . However, the CAT vector (pBLW2) was 27-fold less responsive than the constructs containing gD promoter sequences (Table 1) . It was therefore possible that the gD promoter was activated by a second mechanism which depended on the presence of some promoter elements and therefore occurred at the level of transcription; expression of pgD CAT was increased 4400-fold due to HHV-6 infection (Table 1) . To determine whether a proportion of this increase was mirrored by G H activation, p g D G H was created. Expression of this construct was not detectable with or without HHV-6 infection thus showing HHV-6 to have, at most, a minor effect on this construct; cotransfection with pPRV IE boosted expression of p g D G H to a detectable level (Table 2) .
To show that the effect on the CAT gene was not due to an effect on the activity or stability of the CAT enzyme in the assay, extracts from pgD CAT-transfected cells were mixed in equal proportions with extracts from HHV-6-infected cells (Fig. 8) . No increase in activity was observed compared to that seen with transfected cells mixed with non-infected cell extracts, showing that increased CAT activity is due to elevated gene expression.
Discussion
Our results show that activation by HHV-6 depends on the recorder gene used and that the role of the promoter or enhancer sequences are, at most, of minor importance. Activation of gene expression by HHV-6 is most likely to occur post-transcriptionally because any transcriptional effect would be expected to be independent of the reporter gene used. Ensoli et al. (1989) , whose study of activation centred on the HIV LTR, reach strikingly different conclusions. They found no induction of HTLV-I L T R -C A T constructs by HHV-6 and they observed also that HHV-6 infection increased the level of HIV mRNA, whereas we found no increase in accumulated HTLV-I mRNA. In addition, Ensoli et al. mapped the HHV-6-responsive elements to between 105 and 80 bp upstream of the HIV m R N A start site; these elements serve as the binding sites for the NFkB transcription factor. We found that no specific promoter sequences were necessary for activation, including those containing NFkB binding elements (Fig. 8) . The variation between our results and those of Ensoli and co-workers is unlikely to be due to differences in experimental procedure, as we have repeated experiments using the methods described by Ensoli et al. (1989) , who used cells preinfected with HHV-6 for transfection. This change in procedure made no difference to the ubiquitous nature of CAT activation. We have also carried out experiments in which plasmids were transfected into a second Jurkat cell line, or into H U T 78 cells. Again, non-specific activation of CAT constructs by HHV-6 was observed (data not shown), indicating that our results were unlikely to be cell typedependent. It therefore seems most plausible that the differences between our data and those of Ensoli et al. (1989) are due to differences in the activity or expression of trans-activating polypeptides between the two virus strains. It should be noted, however, that the effect observed in both studies is the average stimulation of a non-co-ordinately infected cell population and the net result may be due to a number of trans-activating polypeptides.
Our results, however, bear a strong similarity to those obtained by Kenney et al. (1988 Kenney et al. ( , 1989 and who studied the EBV BMLFI gene, which encodes an immediate early trans-activator. These workers found activation of all CAT constructs by BMLF1, including those with no recognizable eukaryotic promoter, and they observed no increase in CAT m R N A levels. Most significantly, they found that only CAT constructs and not G H constructs are induced by BMLF1. The similarity between these results and those obtained for HHV-6 suggests that the HHV-6 transactivator may be a homologue of BMLF1. The BMLF1 gene is a member of a family of herpesvirus genes which The mechanism whereby HHV-6 or EBV BMLF-1 activate CAT gene expression is not known. Differences in the level of expression from different recorder gene constructs may not be due solely to the nature of the coding sequences because CAT, TK and GH plasmids also differ in leader sequences, polyadenylation signals and number of introns. Although the highly spliced nature of the GH gene may play some role in the lack of responsiveness to HHV-6, this is unlikely to be the only important factor as we found that HSV-1 TK, an unspliced gene, is only weakly responsive note that the unspliced/~-galactosidase gene is not induced by EBV BMLF1. Differences in leader sequences and polyadenylation signals may account for the variation in induction levels between different CAT constructs. For example, HTLV-I LTR-CAT is upregulated 52-fold whereas pgD CAT is induced 4400-fold. HHV-6 induction may therefore occur by stabilizing mRNA, allowing preferential expression of unspliced mRNA or preferential use of specific polyadenylation signals, or even during the translation process.
It is probable that the CAT gene mirrors some property of a target viral or cellular gene the expression of which is up-regulated by the HHV-6 trans-activator during the course of infection.
